BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses

Reuters
26 Mar
BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy <a href="https://laohu8.com/S/LENZ">Therapeutics</a>, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses

March 26 (Reuters) - Salarius Pharmaceuticals Inc SLRX.O:

  • SALARIUS PHARMACEUTICALS MERGER PARTNER, DECOY THERAPEUTICS, ANNOUNCES ITS NOVEL INHIBITORS SHOW PROMISING IN SILICO ACTIVITY AGAINST MEASLES AND RELATED VIRUSES

Source text: ID:nGNX2Pm53f

Further company coverage: SLRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10